ReviewProstate international2025
Application of robotics in the treatment of benign prostatic hyperplasia: a narrative review.
Review in Prostate international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- A bibliometric analysis of the most-cited studies on robotic nephrectomy versus laparoscopic nephrectomy: Citation trends and scientific influence.Investigative and clinical urology · 2026Review
- Holmium laser enucleation of the prostate versus transurethral resection of the prostate for benign prostatic hyperplasia: evidence from a Korean retrospective analysis using the Common Data Model.Prostate international · 2026Article
- Quality-of-life outcomes following Aquablation in men with poor initial quality of life: pooled analysis of five international studies.Prostate international · 2026Article
- Research progress on ejaculatory function preservation in minimally invasive surgical treatments for benign prostatic hyperplasia: a narrative review.Translational andrology and urology · 2025Review
- Integrated management strategies for benign prostatic hyperplasia.Frontiers in urology · 2025Review
- Efficacy and safety of low-power holmium laser enucleation of the prostate: experience gained from more than 700 cases.Turkish journal of medical sciences · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A range of surgical approaches are available for treating benign prostatic hyperplasia (BPH), with emphasis placed not only on their effectiveness but also on minimizing invasiveness. The advent of surgical robotics has revolutionized BPH treatment, with robot-assisted simple prostatectomy offering a less invasive alternative to traditional approaches. The emergence of single-port systems has also earned attention for being effective in confined spaces. Aquablation represents a distinct robotic platform utilizing a heat-free, high-velocity waterjet to ablate prostate adenomas according to pre-registered configurations under real-time imaging. These novel technologies have proven to treat large prostates exceeding 80 mL efficiently and safely. Furthermore, Aquablation, along with technical modifications such as urethra-sparing robot-assisted simple prostatectomy, have demonstrated effectiveness in preserving ejaculatory function, thereby enhancing patients' overall quality of life. As evidence accumulates and technology and techniques evolve, robotic interventions for BPH may serve as a new standard in the field in the future.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.